What did @mesa_trt actually say?
The creator from Mesa TRT walked through testosterone injection basics, covering intramuscular versus subcutaneous delivery, then made a specific scheduling claim: "two days a week, we find this optimum." They also mentioned that some patients are told to inject daily as a microdosing strategy. The video frames twice-weekly dosing as a clear upgrade over the once-weekly or every-other-week schedules many other clinics use.
That scheduling claim is the part worth scrutinizing. The IM vs. subcutaneous distinction is generally sound. But when a clinic says their dosing frequency is "optimum," that word is doing a lot of work and deserves pushback.
Does the science back this up?
Partly, yes. The rationale for splitting doses is real, but "optimum" is a stronger claim than the evidence supports for every patient. Testosterone cypionate has a half-life of roughly 8 days, and enanthate around 4-5 days. That is longer than the creator suggests when they say "a few days."
More frequent injections do reduce peak-to-trough variability, which matters for symptom stability and hematocrit management. A 2017 study by Spratt et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that more frequent, smaller doses produce steadier serum testosterone levels compared to less frequent large doses. A 2021 review by Handelsman in Endocrine Reviews also supports that injection frequency affects hormonal steadiness. However, no large randomized controlled trial has declared twice-weekly dosing categorically superior for all TRT patients. Daily microdosing has clinical rationale but even less formal trial data behind it.
What did they get wrong (or right)?
The half-life claim is the clearest factual error here. Testosterone cypionate has a half-life closer to 8 days, not "a few days." This matters because the half-life is exactly the pharmacokinetic reason clinicians argue about dosing schedules. Getting it wrong undermines the explanation, even if the practical recommendation ends up reasonable.
The IM versus subcutaneous framing is accurate. Research by Kaminetsky et al. (2011, Journal of Sexual Medicine) and subsequent clinical experience have confirmed that subcutaneous testosterone injection is a legitimate, well-tolerated delivery route that produces stable serum levels. Credit where it is due: the creator is not wrong to present both as valid options.
The framing of twice-weekly as "optimum" is an overclaim. It may be optimal for many patients, and the physiological logic is solid. But patients on longer ester formulations injecting every two weeks can also maintain acceptable levels if monitored properly. Calling one schedule universally optimum oversimplifies individualized care.
What should you actually know?
Injection frequency should be driven by your specific ester, your lab values, and how you feel, not a blanket protocol. Testosterone cypionate and enanthate are the two most common esters in the U.S., and their longer half-lives mean every-other-week dosing is not automatically wrong for everyone. It does, however, create wider hormonal swings that some patients notice as mood and energy fluctuations.
Subcutaneous injection into abdominal fat or the lateral thigh is supported by real clinical data and is genuinely easier for self-injection. If your current protocol uses IM only, asking your provider about subcutaneous is a reasonable conversation.
- Twice-weekly dosing reduces hormonal peaks and troughs, which most endocrinologists consider a practical benefit.
- Daily microdosing has biological rationale but is not standard of care and requires more patient burden.
- Always confirm your injection schedule with the provider managing your labs, not a TikTok protocol.
Bottom line
This video gets the fundamentals directionally correct but overstates certainty. The half-life error is a real inaccuracy that a clinic operating at this scale should not be making publicly. The twice-weekly recommendation is reasonable clinical practice, but labeling it "optimum" without acknowledging patient variability or ester differences is the kind of confident overreach that sounds authoritative and is not fully earned by the data.